6 of the best performing ASX All Ords stocks in the past year
Clarity Pharmaceuticals (ASX:CU6)
Clarity is a late-stage clinical biotech, testing its Targeted Copper Theranostics (TCT) technology in a pivotal clinical trial. TCT is a radiation-based therapy that delivers treatment directly to the cells rather than the outside. This is the type of…
Basic Materials
Investors fear a US recession - there's no denying it and there's no other explanation for the market correction in the last week. But are these fears justified?
Why investors fear a US recession
Because there are data points that are showing markets could be headed that way. There was a very fine tightrope central banks…
Here are 4 ASX 200 stocks you should sell in FY25
One of the common criticisms of brokers and analysts is that they are fast to tell you when to buy a stock, but hesitant to tell you when to sell. Even when some will tell you when to sell a stock, the buy or…
Iron ore demand from China has been the driving force behind the global iron ore market for the past two decades. With Beijing being the world's largest steel producer and iron ore importer and because it has had what has seemed an insatiable appetite for iron ore, China has shaped the dynamics of the industry.…
The pricе-to-еarnings ratio of Adbri (ASX:ABC) is 18.8x, which is lower than the ratios of many other Australian companies, indicating that this may be an interesting opportunity. This low pricе-to-еarnings ratio, on thе other hand, maybе a reflection of the company's rеcеnt earnings dеclinе, with profits falling at a fastеr ratе than thosе of othеr…
